Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oberweis Small-Cap Opportunities Fund (OBSOX)

16.05
Net Asset Value
-0.74%
1 Day
+12.08%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
2.18%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize capital appreciation. The fund invests normally at least 80% of its net assets in the securities of small-cap companies. Its investment adviser considers small-cap companies as those with a market capitalization of less than $5 billion at the time of investment. The fund invests principally in the common stocks of companies that the adviser believes have the potential for significant long-term growth in market value. It invests in those companies which the adviser considers to have above-average long-term growth potential.

Performance

1 month-6.41% 3 years+15.68%
3 months-1.83% 5 years+17.29%
1 year+10.20% Since inception+7.01%
Data through --

Peer Comparisonvs. Small growth

 OBSOXCategory
Performance 5-yr return+17.29%+17.65%
Expense ratio2.18%1.37%
Risk 5 year sharpe ratio0.970.99
Net assets$12.8M$840.8M
Average market cap$2.0B$3.0B
Average P/E29.829.8
Portfolio turnover107%107%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOberweis
Fund manager & tenureJames Oberweis / 13 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock95.60%
International stock2.66%
Fixed income1.74%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Hardware 18.79%
Consumer goods 16.61%
Industrial materials 15.00%
Healthcare 12.67%
Business service 11.99%
Top 10 Holdings
Portfolio weighting
DPLO Diplomat Pharmacy Inc2.74%
DXCM DexCom Inc2.64%
SYNA Synaptics Inc2.21%
SKX Skechers USA Inc1.87%
CSII Cardiovascular Systems Inc1.78%
CBM Cambrex Corp1.76%
TREX Trex Co Inc1.72%
ABMD Abiomed Inc1.71%
SNCR Synchronoss Technologies Inc1.70%
ATRO Astronics Corp1.67%

Partner Offers